A, S., M, G., A, H., & C, B. (2019). Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder. ClinicoEconomics and outcomes research : CEOR, 11, 741. https://doi.org/10.2147/CEOR.S220007
Chicago Style (17th ed.) CitationA, Seetasith, Greene M, Hartry A, and Burudpakdee C. "Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder." ClinicoEconomics and Outcomes Research : CEOR 11 (2019): 741. https://doi.org/10.2147/CEOR.S220007.
MLA (9th ed.) CitationA, Seetasith, et al. "Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive Disorder." ClinicoEconomics and Outcomes Research : CEOR, vol. 11, 2019, p. 741, https://doi.org/10.2147/CEOR.S220007.